Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liquid Risperidone for Acute Agitation in Children
NCT00790075Phase 4Completed
- Sponsor
- Stony Brook University
- Start
- Jan 2003
- Primary completion
- Jun 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of risperidone in agitation, sponsored by Stony Brook University. Primary endpoint: Reduced time to end of agitation episode compared to unmedicated agitation episode. Started Jan 2003; status: completed.
02
Drugs
risperidone
03
Conditions
agitation
Beyond the preview
Go deeper on NCT00790075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00790075.